Biologik ApS: Financial statements 2022
CVR: 36070498
Source: annual report 2022, Danish Business Authority
01/07/2021 – 30/06/2022
Biologik ApS (CVR 36070498) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 258,073 and a net result of DKK -89,361 compared with DKK 214,892 the year before. That is a decrease of 56.5% compared with the year before. Equity in the 2022 report amounted to DKK 267,866. The solvency ratio was 61.2%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 258,073
- Profit/Loss
- DKK -89,361
- Equity
- DKK 267,866
- Total Assets
- DKK 437,363
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 258 t. | -89 t. | 268 t. | 1 |
| 2021 | - | 593 t. | 215 t. | 414 t. | 1 |
| 2020 | - | 378 t. | 62 t. | 199 t. | 1 |
| 2019 | - | 832 t. | 183 t. | 237 t. | 1 |
| 2018 | - | 714 t. | 174 t. | 107 t. | 1 |
Official annual report
Keep an eye on Biologik ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout Biologik ApS
Biologik ApS is a Danish company of the type Anpartsselskab based in Kgs. Lyngby, founded in 2014. The company is registered under the industry Drift af sundhedsvæsen i øvrigt i.a.n.. The management consists of Anette Sams Nielsen. The company is owned by Helms & Sams ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 385,601 and a net result of DKK 234,499 compared with DKK -35,348 the year before. Equity in the 2025 report amounted to DKK 408,578.